Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Afamelanotide [2] AFAMELANOTIDE; SCENESSE[1] Afamelanotide 💬[1] MC1R 💬[2] Melanogenesis, Neuroactive ligand-receptor interaction 💬[3] 159, 161, 254 💬
2 Ipilimumab [1] Ipilimumab[1] Ipilimumab 💬[1] CTLA4 💬[4] Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬[1] 159 💬
3 Isotretinoin [1] Isotretinoin[1] Isotretinoin 💬[2] RARA,
RARB 💬
[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 36, 39, 159, 160 💬
4 Nivolumab [1] Nivolumab[1] Nivolumab 💬[1] PDCD1 💬[3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
5 Trabectedin [2] TRABECTEDINA; Yondelis[1] Trabectedin 💬--[1] 159 💬